JAC1 suppresses proliferation of breast cancer through the JWA/p38/SMURF1/HER2 signaling

被引:14
|
作者
Ren, Yanlin [1 ,2 ,5 ]
Chen, Dongyin [3 ]
Zhai, Zurong [1 ,2 ]
Chen, Junjie [1 ,2 ]
Li, Aiping [1 ,2 ]
Liang, Yan [2 ,4 ]
Zhou, Jianwei [1 ,2 ]
机构
[1] Nanjing Med Univ, Sch Publ Hlth, Ctr Global Hlth, Dept Mol Cell Biol & Toxicol, Nanjing 211166, Peoples R China
[2] Nanjing Med Univ, Collaborat Innovat Ctr Canc Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatm, Nanjing 211166, Peoples R China
[3] Nanjing Med Univ, Sch Pharm, Dept Med Chem, Nanjing 211166, Peoples R China
[4] Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Nanjing 211166, Peoples R China
[5] Nantong Ctr Dis Control & Prevent, Nantong 226007, Peoples R China
基金
中国国家自然科学基金;
关键词
CELL-PROLIFERATION; GASTRIC-CANCER; LUNG-CANCER; JWA; EXPRESSION; GROWTH; RESISTANCE; MIGRATION; INVASION; HER2;
D O I
10.1038/s41420-021-00426-y
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The overexpression of HER2 is associated with a malignant proliferation of breast cancer. In this study, we developed a non-cytotoxic JWA gene activating compound 1 (JAC1) to inhibit the proliferation of HER2-positive breast cancer cells in vitro and in vivo experimental models. JAC1 increased the ubiquitination of HER2 at the K716 site through the E3 ubiquitin ligase SMURF1 which was due to the decreased expression of NEDD4, the E3 ubiquitin ligase of SMURF1. In conclusion, JAC1 suppresses the proliferation of HER2-positive breast cancer cells through the JWA triggered HER2 ubiquitination signaling. JAC1 may serve as a potential therapeutic agent for HER2-positive breast cancer.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Effects of MiR-194-5p on the proliferation and invasion of laryngeal cancer cells by regulating the expression of Smurf1 and activating the mTOR signaling pathway
    Yang, You
    Zeng, Qingwei
    Sun, Shiping
    Zhang, Min
    Liu, Wen
    Song, Daoliang
    CELLULAR AND MOLECULAR BIOLOGY, 2022, 68 (06) : 79 - 83
  • [22] Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2
    Wang, Guanwen
    Wang, Juan
    Chang, Antao
    Cheng, Dongmei
    Huang, Shan
    Wu, Dan
    Sirkisoon, Sherona
    Yang, Shuang
    Lin, Hui-Kuan
    Lo, Hui-Wen
    Xiang, Rong
    Sun, Peiqing
    ONCOGENE, 2020, 39 (47) : 7034 - 7050
  • [23] A Transcriptional Link between HER2, JAM-A and FOXA1 in Breast Cancer
    Cruz, Rodrigo G. B.
    Madden, Stephen F.
    Brennan, Kieran
    Hopkins, Ann M.
    CELLS, 2022, 11 (04)
  • [24] Erythro-austrobailignan-6 down-regulates HER2/EGFR/integrin β3 expression via p38 activation in breast cancer
    Han, Jae-hyun
    Jeong, Ha Jin
    Lee, Han Na
    Kwon, Yun Ju
    Shin, Heung-Mook
    Choi, Yura
    Lee, Seongmi
    Oh, Seung Tack
    Kim, Dong-il
    Jeon, Songhee
    PHYTOMEDICINE, 2017, 24 : 24 - 30
  • [25] Methanolic Leaves Extract of Ziziphus spina-christi Inhibits Cell Proliferation and Migration of HER2-Positive Breast Cancer via p38 MAPK Signaling Pathway
    Saeed, Sumayyah
    Hassan, Arij Fouzat
    Suliman, Azza
    Al Moustafa, Ala-Eddin
    Alali, Feras
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (02)
  • [26] WASF3 provides the conduit to facilitate invasion and metastasis in breast cancer cells through HER2/HER3 signaling
    Teng, Y.
    Pi, W.
    Wang, Y.
    Cowell, J. K.
    ONCOGENE, 2016, 35 (35) : 4633 - 4640
  • [27] Rap1A promotes ovarian cancer metastasis via activation of ERK/p38 and notch signaling
    Lu, Lili
    Wang, Jingshu
    Wu, Yougen
    Wan, Ping
    Yang, Gong
    CANCER MEDICINE, 2016, 5 (12): : 3544 - 3554
  • [28] LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR/p38 signaling
    Xie, Zhi-Bo
    Zhang, Yi-Fan
    Jin, Chen
    Mao, Yi-Shen
    Fu, De-Liang
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [29] Astrocyte elevated gene-1 induces breast cancer proliferation and invasion through upregulating HER2/neu expression
    Zhang Xin
    Zhang Ning
    Zhang Mei-xin
    CHINESE MEDICAL JOURNAL, 2011, 124 (21) : 3546 - 3550
  • [30] TIPE2 suppresses the tumorigenesis, growth and metastasis of breast cancer via inhibition of the AKT and p38 signaling pathways
    Zhang, Zhenhua
    Liu, Li
    Liu, Chunliang
    Cao, Shousong
    Zhu, Yizhun
    Mei, Qibing
    ONCOLOGY REPORTS, 2016, 36 (06) : 3311 - 3316